Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Harvard Apparatus Regenerative Technology Inc. (HRGN)

Compare
1.8580
0.0000
(0.00%)
At close: April 10 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
430
430
103
--
--
Cost of Revenue
270
270
24
--
--
Gross Profit
160
160
79
--
--
Operating Expense
7,886
7,886
9,069
6,153
8,471
Operating Income
-7,726
-7,726
-8,990
-6,153
-8,471
Net Non Operating Interest Income Expense
-6
-6
50
-9
--
Other Income Expense
110
--
-5
89
493
Pretax Income
-7,732
-7,732
-8,945
-6,073
-7,978
Net Income Common Stockholders
-7,732
-7,732
-9,022
-6,253
-7,978
Diluted NI Available to Com Stockholders
-7,732
-7,732
-9,022
-6,253
-7,978
Basic EPS
-0.52
--
-0.67
-0.55
-0.79
Diluted EPS
-0.52
--
-0.67
-0.55
-0.79
Basic Average Shares
14,789.3320
--
13,455.6660
11,349.6100
10,062
Diluted Average Shares
14,789.3320
--
13,455.6660
11,349.6100
10,062
Total Operating Income as Reported
-7,726
-7,726
-8,990
-6,153
-8,636
Total Expenses
8,156
8,156
9,093
6,153
8,471
Net Income from Continuing & Discontinued Operation
-7,732
-7,732
-8,945
-6,073
-7,978
Normalized Income
-7,732
-7,732
-8,945
-6,075
-8,401
Interest Income
32
32
64
--
--
Interest Expense
38
38
14
9
--
Net Interest Income
-6
-6
50
-9
--
EBIT
-7,694
-7,694
-8,931
-6,064
-8,471
EBITDA
-7,527
-7,527
-8,797
-5,990
-8,364
Reconciled Cost of Revenue
270
270
24
--
--
Reconciled Depreciation
167
167
134
74
107
Net Income from Continuing Operation Net Minority Interest
-7,732
-7,732
-8,945
-6,073
-7,978
Total Unusual Items Excluding Goodwill
31
--
--
2
423
Total Unusual Items
31
--
--
2
423
Normalized EBITDA
-7,527
-7,527
-8,797
-5,992
-8,787
12/31/2021 - 10/21/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1541.HK IMMUNEONCO-B
5.140
+3.84%
 
AKESF Akeso, Inc.
9.30
0.00%
 
SLN Silence Therapeutics plc
2.1900
+0.46%
 
GLYC GlycoMimetics, Inc.
0.1946
+1.25%
 
9926.HK Akeso, Inc.
81.600
+10.05%
 
TIL Instil Bio, Inc.
14.18
-6.22%
 
MGNX MacroGenics, Inc.
1.2500
-1.57%
 
CARM Carisma Therapeutics, Inc.
0.1990
+0.66%
 
LEGN Legend Biotech Corporation
31.28
-2.49%
 
NUVB Nuvation Bio Inc.
1.7500
-2.23%